Annual Operating Expenses
$10.11 M
+$178.00 K+1.79%
December 1, 2024
Summary
- As of March 10, 2025, ARTL annual total operating expenses is $10.11 million, with the most recent change of +$178.00 thousand (+1.79%) on December 1, 2024.
- During the last 3 years, ARTL annual operating expenses has risen by +$6.07 million (+150.07%).
- ARTL annual operating expenses is now -1.74% below its all-time high of $10.29 million, reached on December 31, 2022.
Performance
ARTL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$3.81 M
+$2.62 M+219.00%
December 1, 2024
Summary
- As of March 10, 2025, ARTL quarterly total operating expenses is $3.81 million, with the most recent change of +$2.62 million (+219.00%) on December 1, 2024.
- Over the past year, ARTL quarterly operating expenses has stayed the same.
- ARTL quarterly operating expenses is now -70.17% below its all-time high of $12.78 million, reached on December 1, 2010.
Performance
ARTL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ARTL Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.8% | 0.0% |
| 3 y3 years | +150.1% | +49.4% |
| 5 y5 years | +115.7% | +165.5% |
ARTL Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.7% | +150.1% | at high | +219.0% |
| 5 y | 5-year | -1.7% | +214.9% | at high | +300.7% |
| alltime | all time | -1.7% | >+9999.0% | -70.2% | >+9999.0% |
Artelo Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $10.11 M(+1.8%) | $3.81 M(+219.0%) |
| Sep 2024 | - | $1.20 M(-52.4%) |
| Jun 2024 | - | $2.51 M(-3.0%) |
| Mar 2024 | - | $2.59 M(-20.1%) |
| Dec 2023 | $9.93 M(-3.5%) | $3.24 M(+23.9%) |
| Sep 2023 | - | $2.61 M(+46.5%) |
| Jun 2023 | - | $1.78 M(-22.2%) |
| Mar 2023 | - | $2.29 M(-34.1%) |
| Dec 2022 | $10.29 M(+154.5%) | $3.48 M(+45.2%) |
| Sep 2022 | - | $2.39 M(-3.1%) |
| Jun 2022 | - | $2.47 M(+27.0%) |
| Mar 2022 | - | $1.95 M(-23.7%) |
| Dec 2021 | $4.04 M(-45.7%) | - |
| Nov 2021 | - | $2.55 M(+35.2%) |
| Aug 2021 | $7.44 M(+58.8%) | $1.89 M(-16.2%) |
| May 2021 | - | $2.25 M(+20.6%) |
| Feb 2021 | - | $1.87 M(+30.0%) |
| Nov 2020 | - | $1.44 M(+39.7%) |
| Aug 2020 | $4.69 M(+46.0%) | $1.03 M(+8.0%) |
| May 2020 | - | $951.40 K(-30.6%) |
| Feb 2020 | - | $1.37 M(+2.6%) |
| Nov 2019 | - | $1.34 M(+40.2%) |
| Aug 2019 | $3.21 M(+37.0%) | $953.40 K(+1.3%) |
| May 2019 | - | $941.30 K(+24.2%) |
| Feb 2019 | - | $757.90 K(+36.1%) |
| Nov 2018 | - | $556.90 K(-19.3%) |
| Aug 2018 | $2.34 M | $690.10 K(+19.4%) |
| May 2018 | - | $577.90 K(-27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2018 | - | $798.50 K(+188.2%) |
| Nov 2017 | - | $277.10 K(+139.7%) |
| Aug 2017 | $232.80 K(+683.8%) | $115.60 K(+20.8%) |
| May 2017 | - | $95.70 K(+697.5%) |
| Feb 2017 | - | $12.00 K(+26.3%) |
| Nov 2016 | - | $9500.00(+120.9%) |
| Aug 2016 | $29.70 K(+95.4%) | $4300.00(-14.0%) |
| May 2016 | - | $5000.00(-2.0%) |
| Feb 2016 | - | $5100.00(-66.4%) |
| Nov 2015 | - | $15.20 K(+230.4%) |
| Aug 2015 | $15.20 K(-0.7%) | $4600.00(+84.0%) |
| May 2015 | - | $2500.00(-59.7%) |
| Feb 2015 | - | $6200.00(+210.0%) |
| Nov 2014 | - | $2000.00(+300.0%) |
| Aug 2014 | $15.30 K | $500.00(-93.8%) |
| May 2014 | - | $8100.00(+22.7%) |
| Feb 2014 | - | $6600.00(-99.9%) |
| Jun 2011 | - | $7.50 M(-2.8%) |
| Mar 2011 | - | $7.71 M(-39.6%) |
| Dec 2010 | - | $12.78 M(+68.0%) |
| Sep 2010 | - | $7.61 M(+0.8%) |
| Jun 2010 | - | $7.54 M(+6.3%) |
| Mar 2010 | - | $7.10 M(+5.2%) |
| Dec 2009 | - | $6.75 M(+0.3%) |
| Sep 2009 | - | $6.73 M(-2.2%) |
| Jun 2009 | - | $6.88 M(+4.6%) |
| Mar 2009 | - | $6.58 M(+5.4%) |
| Dec 2008 | - | $6.24 M(+33.5%) |
| Sep 2008 | - | $4.67 M |
FAQ
- What is Artelo Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Artelo Biosciences?
- What is Artelo Biosciences annual operating expenses year-on-year change?
- What is Artelo Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Artelo Biosciences?
- What is Artelo Biosciences quarterly operating expenses year-on-year change?
What is Artelo Biosciences annual total operating expenses?
The current annual operating expenses of ARTL is $10.11 M
What is the all time high annual operating expenses for Artelo Biosciences?
Artelo Biosciences all-time high annual total operating expenses is $10.29 M
What is Artelo Biosciences annual operating expenses year-on-year change?
Over the past year, ARTL annual total operating expenses has changed by +$178.00 K (+1.79%)
What is Artelo Biosciences quarterly total operating expenses?
The current quarterly operating expenses of ARTL is $3.81 M
What is the all time high quarterly operating expenses for Artelo Biosciences?
Artelo Biosciences all-time high quarterly total operating expenses is $12.78 M
What is Artelo Biosciences quarterly operating expenses year-on-year change?
Over the past year, ARTL quarterly total operating expenses has changed by $0.00 (0.00%)